GARY S. JACOB - 16 May 2022 Form 3 Insider Report for OKYO Pharma Ltd (OKYO)

Role
Chief Executive Officer, Director
Signature
/s/ Gary S. Jacob
Issuer symbol
OKYO
Transactions as of
16 May 2022
Net transactions value
$0
Form type
3
Filing time
16 May 2022, 17:44:20 UTC
Previous filing
05 Jan 2022
Next filing
19 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OKYO Option (right to buy) 16 May 2022 Ordinary Shares 40,000,000 $0.0653 Direct F1
holding OKYO Option (right to buy) 16 May 2022 Ordinary Shares 13,000,000 $0.0640 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% will vest each year on January 7, beginning on January 6, 2021.
F2 25% will vest each year on January 7, beginning on August 31, 2021.